Trademark Overview
On Tuesday, December 10, 2024, a trademark application was filed for FLUVIXVY with the United States Patent and Trademark Office. The USPTO has given the FLUVIXVY trademark a serial number of 98893674. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, December 10, 2024. This trademark is owned by GlaxoSmithKline Biologicals SA. The FLUVIXVY trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders